Stay updated on Nivolumab Dose Optimization Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Dose Optimization Clinical Trial page.

Latest updates to the Nivolumab Dose Optimization Clinical Trial page
- Check3 days agoChange DetectedThe page is updated to v3.0.2: it removes the Lung cancer topic under MedlinePlus Genetics and the Back to Top link, replacing the previous v3.0.1 tag with v3.0.2.SummaryDifference0.3%
- Check11 days agoChange DetectedThe web page has been updated to include information on Lung cancer under MedlinePlus Genetics topics, and the version has been revised from v3.0.0 to v3.0.1.SummaryDifference0.3%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of multiple facility names and locations across various countries, while also removing some previously listed locations and related topics. The revision number has been updated to v3.0.0.SummaryDifference3%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check46 days agoChange DetectedThe web page has been updated to version v2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.7%
Stay in the know with updates to Nivolumab Dose Optimization Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Dose Optimization Clinical Trial page.